Navigation Links
Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio
Date:8/16/2010

Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio -- CLEVELAND, Ohio, August 16, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Electronics, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Supplementary Medicine, Clinical Trials & Medical Discoveries, FDA Approval Click to view news release full screen  

Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio

 

CLEVELAND, Ohio, August 16, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, will consolidate its eTrinsic custom courseware business currently located in Denver, Colorado and relocate those operations to its Corporate Headquarters in Cleveland, Ohio under its expanding Medical Education Division (MED).

The move will enable Simbionix to better focus on its strategic direction, enhance its mobile and web-based medical education products and services, and improve reaction to customer and market needs. "This is a very exciting time for Simbionix", stated Paul Jensen, the GM of the new and expanding Medical Education Division, "we are developing a number of innovative products. Having everyone in one location will facilitate collaboration across the team and improve our ability to rapidly deliver high-quality solutions."

The company recently announced the expansion of its Corporate Headquarters. The move will be completed by the end of September 2010.

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com Contact: Rebecca Zitter Manager of Marketing Communications and Distributor Relations Rebecca@simbionix.com +1-216-229-2040
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix Continues its Global Expansion
2. Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting
3. Simbionix ANGIO Mentor Plays Important Role in Physician Training and Certification
4. Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies
5. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
6. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
7. Simbionix Increases Product Offerings for OB/GYN Physicians
8. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
9. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
10. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
11. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  UBM and the ... announce their extended partnership and the third annual Massachusetts ... by the 21 st Annual MassMEDIC Conference ... place May 3-4, 2017. MassMEDIC ... Association (ADVAMED) President and CEO, Scott Whitaker ...
(Date:3/22/2017)... , March 22, 2017 Oramed ... ( www.oramed.com ), a ... oral drug delivery systems, announced today that Dr. ... will deliver a presentation titled, "Oral Insulin for ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) ...
(Date:3/22/2017)... , March 22, 2017 ... fragmented, states a research report by Transparency Market Research ... Inc., Amgen Inc., and AbbVie Inc., accounted for a ... The prominent players in this market are focusing aggressively ... product portfolio, which is likely to lead to market ...
(Date:3/22/2017)... /PRNewswire/ - FACIT announced a seed stage investment ... start-up created by FACIT focused on developing a ... with non-dilutive capital, achieves a targeted $3.0M financing ... Propellon to accelerate the nomination of a candidate ... entering a strategic partnership for clinical trials in ...
Breaking Biology Technology:
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... 28, 2017 News solutions for biometrics, bag ... ... from 14 to 16 March, Materna will present its complete ... seamless travel is a real benefit for passengers. To accelerate ... their passenger touch point solutions to take passengers through the complete ...
(Date:2/26/2017)... Feb. 25, 2017  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announces ... Reentry. "Too often, too many offenders ... county jails are trying to tackle this ongoing ... friends and family members. While significant steps are underway, ...
Breaking Biology News(10 mins):